沟通型 DeBakey IIIb 慢性主动脉夹层动脉瘤初次手术修复的长期疗效

Shuhei Miura MD, Yutaka Iba MD, PhD, Kei Mukawa MD, Keitaro Nakanishi MD, Takakimi Mizuno MD, Ayaka Arihara MD, Tsuyoshi Shibata MD, PhD, Junji Nakazawa MD, PhD, Tomohiro Nakajima MD, PhD, Nobuyoshi Kawaharada MD, PhD
{"title":"沟通型 DeBakey IIIb 慢性主动脉夹层动脉瘤初次手术修复的长期疗效","authors":"Shuhei Miura MD,&nbsp;Yutaka Iba MD, PhD,&nbsp;Kei Mukawa MD,&nbsp;Keitaro Nakanishi MD,&nbsp;Takakimi Mizuno MD,&nbsp;Ayaka Arihara MD,&nbsp;Tsuyoshi Shibata MD, PhD,&nbsp;Junji Nakazawa MD, PhD,&nbsp;Tomohiro Nakajima MD, PhD,&nbsp;Nobuyoshi Kawaharada MD, PhD","doi":"10.1016/j.xjon.2024.05.009","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><p>This study aimed to evaluate the long-term outcomes of surgical strategies for communicating DeBakey IIIb chronic dissecting aortic aneurysm, considering the optimal primary surgical repair to prevent aortic events.</p></div><div><h3>Methods</h3><p>From 2002 to 2021, 101 patients with communicating DeBakey IIIb chronic dissecting aortic aneurysm who underwent surgical repair were categorized based on the primary surgical repair: 1-stage repair of thoracoabdominal aortic aneurysm (TAAAR) (n = 22) or staged repair, such as descending thoracic aneurysm repair (DTAR) (n = 43) or total arch replacement with elephant trunk implantation (TARET) (n = 25), and thoracic endovascular aortic repair (TEVAR) (n = 11). Early and late postoperative outcomes were compared among the groups.</p></div><div><h3>Results</h3><p>Early outcomes for TAAAR, DTAR, TARET, and TEVAR were associated with the incidence of stroke (9.1% vs 0% vs 4.0% vs 9.1%, respectively), spinal cord injury (13.6% vs 4.7% vs 8.0% vs 0%, respectively), and in-hospital mortality (9.1% vs 2.3% vs 0% vs 9.1%, respectively). During follow-up, the 10-year overall survival and 7-year aortic event-free rates for TAAAR, DTAR, TARET, and TEVAR were 61.8%, 71.6%, 21.5%, and 26.5% and 93.8%, 84.3%, 74.4%, and 51.4%, respectively. TAAAR had significantly higher overall survival (<em>P</em> = .05) and aortic event-free rates (<em>P</em> = .03) than TEVAR. TARET (hazard ratio, 2.27; <em>P</em> &lt; .01) and TEVAR (hazard ratio, 3.40; <em>P</em> &lt; .01) were independently associated with the incidence of aortic events during follow-up.</p></div><div><h3>Conclusions</h3><p>Considering the optimal primary surgical repair based on long-term outcomes, TEVAR was not a durable treatment option. Patient-specific TAAAR or DTAR should be considered rather than defaulting to minimally invasive primary repairs for all patients with communicating DeBakey IIIb chronic dissecting aortic aneurysm.</p></div>","PeriodicalId":74032,"journal":{"name":"JTCVS open","volume":"20 ","pages":"Pages 1-13"},"PeriodicalIF":0.0000,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666273624001293/pdfft?md5=12a1cfd48f6c60ac1e3e2435c9c36f1e&pid=1-s2.0-S2666273624001293-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Long-term outcomes of primary surgical repair for communicating DeBakey IIIb chronic dissecting aortic aneurysm\",\"authors\":\"Shuhei Miura MD,&nbsp;Yutaka Iba MD, PhD,&nbsp;Kei Mukawa MD,&nbsp;Keitaro Nakanishi MD,&nbsp;Takakimi Mizuno MD,&nbsp;Ayaka Arihara MD,&nbsp;Tsuyoshi Shibata MD, PhD,&nbsp;Junji Nakazawa MD, PhD,&nbsp;Tomohiro Nakajima MD, PhD,&nbsp;Nobuyoshi Kawaharada MD, PhD\",\"doi\":\"10.1016/j.xjon.2024.05.009\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objective</h3><p>This study aimed to evaluate the long-term outcomes of surgical strategies for communicating DeBakey IIIb chronic dissecting aortic aneurysm, considering the optimal primary surgical repair to prevent aortic events.</p></div><div><h3>Methods</h3><p>From 2002 to 2021, 101 patients with communicating DeBakey IIIb chronic dissecting aortic aneurysm who underwent surgical repair were categorized based on the primary surgical repair: 1-stage repair of thoracoabdominal aortic aneurysm (TAAAR) (n = 22) or staged repair, such as descending thoracic aneurysm repair (DTAR) (n = 43) or total arch replacement with elephant trunk implantation (TARET) (n = 25), and thoracic endovascular aortic repair (TEVAR) (n = 11). Early and late postoperative outcomes were compared among the groups.</p></div><div><h3>Results</h3><p>Early outcomes for TAAAR, DTAR, TARET, and TEVAR were associated with the incidence of stroke (9.1% vs 0% vs 4.0% vs 9.1%, respectively), spinal cord injury (13.6% vs 4.7% vs 8.0% vs 0%, respectively), and in-hospital mortality (9.1% vs 2.3% vs 0% vs 9.1%, respectively). During follow-up, the 10-year overall survival and 7-year aortic event-free rates for TAAAR, DTAR, TARET, and TEVAR were 61.8%, 71.6%, 21.5%, and 26.5% and 93.8%, 84.3%, 74.4%, and 51.4%, respectively. TAAAR had significantly higher overall survival (<em>P</em> = .05) and aortic event-free rates (<em>P</em> = .03) than TEVAR. TARET (hazard ratio, 2.27; <em>P</em> &lt; .01) and TEVAR (hazard ratio, 3.40; <em>P</em> &lt; .01) were independently associated with the incidence of aortic events during follow-up.</p></div><div><h3>Conclusions</h3><p>Considering the optimal primary surgical repair based on long-term outcomes, TEVAR was not a durable treatment option. Patient-specific TAAAR or DTAR should be considered rather than defaulting to minimally invasive primary repairs for all patients with communicating DeBakey IIIb chronic dissecting aortic aneurysm.</p></div>\",\"PeriodicalId\":74032,\"journal\":{\"name\":\"JTCVS open\",\"volume\":\"20 \",\"pages\":\"Pages 1-13\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S2666273624001293/pdfft?md5=12a1cfd48f6c60ac1e3e2435c9c36f1e&pid=1-s2.0-S2666273624001293-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"JTCVS open\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2666273624001293\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"JTCVS open","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666273624001293","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

本研究旨在评估沟通型DeBakey IIIb慢性剥离性主动脉瘤手术策略的长期疗效,同时考虑到预防主动脉事件的最佳主要手术修复方法。方法从2002年到2021年,101例沟通型DeBakey IIIb慢性剥离性主动脉瘤患者接受了手术修复,根据主要手术修复方法进行分类:一期胸腹主动脉瘤修补术(TAAAR)(22 例)或分期修补术,如降胸动脉瘤修补术(DTAR)(43 例)或象鼻干植入全弓置换术(TARET)(25 例),以及胸腔内血管主动脉修补术(TEVAR)(11 例)。结果TAAAR、DTAR、TARET和TEVAR的早期结果与中风(分别为9.1% vs 0% vs 4.0% vs 9.1%)、脊髓损伤(分别为13.6% vs 4.7% vs 8.0% vs 0%)和院内死亡率(分别为9.1% vs 2.3% vs 0% vs 9.1%)相关。在随访期间,TAAAR、DTAR、TARET和TEVAR的10年总生存率和7年无主动脉事件发生率分别为61.8%、71.6%、21.5%和26.5%,以及93.8%、84.3%、74.4%和51.4%。TAAAR 的总生存率(P = .05)和无主动脉事件发生率(P = .03)明显高于 TEVAR。TARET(危险比,2.27;P <.01)和 TEVAR(危险比,3.40;P <.01)与随访期间主动脉事件的发生率独立相关。对于所有患有交流性DeBakey IIIb型慢性剥脱性主动脉瘤的患者,应考虑针对患者的TAAAR或DTAR,而不是默认采用微创初级修复术。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Long-term outcomes of primary surgical repair for communicating DeBakey IIIb chronic dissecting aortic aneurysm

Objective

This study aimed to evaluate the long-term outcomes of surgical strategies for communicating DeBakey IIIb chronic dissecting aortic aneurysm, considering the optimal primary surgical repair to prevent aortic events.

Methods

From 2002 to 2021, 101 patients with communicating DeBakey IIIb chronic dissecting aortic aneurysm who underwent surgical repair were categorized based on the primary surgical repair: 1-stage repair of thoracoabdominal aortic aneurysm (TAAAR) (n = 22) or staged repair, such as descending thoracic aneurysm repair (DTAR) (n = 43) or total arch replacement with elephant trunk implantation (TARET) (n = 25), and thoracic endovascular aortic repair (TEVAR) (n = 11). Early and late postoperative outcomes were compared among the groups.

Results

Early outcomes for TAAAR, DTAR, TARET, and TEVAR were associated with the incidence of stroke (9.1% vs 0% vs 4.0% vs 9.1%, respectively), spinal cord injury (13.6% vs 4.7% vs 8.0% vs 0%, respectively), and in-hospital mortality (9.1% vs 2.3% vs 0% vs 9.1%, respectively). During follow-up, the 10-year overall survival and 7-year aortic event-free rates for TAAAR, DTAR, TARET, and TEVAR were 61.8%, 71.6%, 21.5%, and 26.5% and 93.8%, 84.3%, 74.4%, and 51.4%, respectively. TAAAR had significantly higher overall survival (P = .05) and aortic event-free rates (P = .03) than TEVAR. TARET (hazard ratio, 2.27; P < .01) and TEVAR (hazard ratio, 3.40; P < .01) were independently associated with the incidence of aortic events during follow-up.

Conclusions

Considering the optimal primary surgical repair based on long-term outcomes, TEVAR was not a durable treatment option. Patient-specific TAAAR or DTAR should be considered rather than defaulting to minimally invasive primary repairs for all patients with communicating DeBakey IIIb chronic dissecting aortic aneurysm.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
1.70
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信